E. Thermophilus, L. Acidophilus, B. Longum, Psyllium Husk

Verify with FDA CVM →

25 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
25
Total Reports
11
Deaths Reported
4400.0%
Death Rate

Active Ingredients

E. Thermophilus, L. Acidophilus, B. Longum, Psyllium Husk

Administration Routes

UnknownOral

Species Affected

Dog 16
Cat 9

Most Affected Breeds

Domestic Shorthair 5
Chihuahua 4
Shih Tzu 3
Persian 1
Mixed (Dog) 1
Terrier - Bull - American Pit 1
Retriever - Labrador 1
Retriever - Golden 1
Dachshund - Miniature 1
Terrier - Yorkshire 1

Most Reported Reactions

Vomiting 8
Death by euthanasia 7
Anorexia 7
Elevated renal parameters 6
Seizure NOS 5
Lethargy (see also Central nervous system depression in 'Neurological') 5
Elevated creatinine 4
Elevated blood urea nitrogen (BUN) 4
Other abnormal test result NOS 4
Death 4
Anaemia NOS 3
Weight loss 3

Outcome Breakdown

Euthanized
7 (28.0%)
Ongoing
6 (24.0%)
Recovered/Normal
5 (20.0%)
Died
4 (16.0%)
Outcome Unknown
3 (12.0%)

Data Summary

Metric Value
Total adverse event reports 25
Reports involving death 11
Case-fatality rate (reported events) 4400.0%
Distinct species in reports 2
Distinct breeds in reports 16
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

E. Thermophilus, L. Acidophilus, B. Longum, Psyllium Husk Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 25 adverse event reports referencing E. Thermophilus, L. Acidophilus, B. Longum, Psyllium Husk, including 11 reports in which the animal died — a 4400.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: E. Thermophilus, L. Acidophilus, B. Longum, Psyllium Husk. Reported administration routes include Unknown, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in E. Thermophilus, L. Acidophilus, B. Longum, Psyllium Husk reports are Dog (16 reports), Cat (9 reports), with Dog accounting for the largest share. Within those species, Domestic Shorthair (5), Chihuahua (4), Shih Tzu (3) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with E. Thermophilus, L. Acidophilus, B. Longum, Psyllium Husk are Vomiting (8), Death by euthanasia (7), Anorexia (7), Elevated renal parameters (6). Of the 25 reports with a coded outcome, Euthanized is the leading category at 28.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on E. Thermophilus, L. Acidophilus, B. Longum, Psyllium Husk.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial